Efficacy of intravitreal Aflibercept in patients with neovascular AMD who were previously treated with Ranibizumab based on a Treat and Extend protocol

被引：0
|
作者：
Turksever, C.
Prunte, C.
Hatz, K.
机构：
来源：
ACTA OPHTHALMOLOGICA | 2015年 / 93卷
关键词：
D O I：
10.1111/j.1755-3768.2015.0396
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
ABS15-0396
引用
收藏
页数：3
相关论文
共 50 条
  • [11] The effect of COVID-19 pandemic restrictions on neovascular AMD patients treated with treat-and-extend protocol
    Mehmet Orkun Sevik
    Aslan Aykut
    Gamze Özkan
    Volkan Dericioğlu
    Özlem Şahin
    International Ophthalmology, 2021, 41 : 2951 - 2961
  • [12] The effect of COVID-19 pandemic restrictions on neovascular AMD patients treated with treat-and-extend protocol
    Sevik, Mehmet Orkun
    Aykut, Aslan
    Ozkan, Gamze
    Dericioglu, Volkan
    Sahin, Ozlem
    INTERNATIONAL OPHTHALMOLOGY, 2021, 41 (09) : 2951 - 2961
  • [13] Intravitreal aflibercept following treat and extend protocol versus fixed protocol for treatment of neovascular age-related macular degeneration
    Abdin, Alaa Din
    Mohamed, Asem
    Munteanu, Cristian
    Weinstein, Isabel
    Langenbucher, Achim
    Seitz, Berthold
    Suffo, Shady
    INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2021, 7 (01)
  • [14] Intravitreal aflibercept following treat and extend protocol versus fixed protocol for treatment of neovascular age-related macular degeneration
    Alaa Din Abdin
    Asem Mohamed
    Cristian Munteanu
    Isabel Weinstein
    Achim Langenbucher
    Berthold Seitz
    Shady Suffo
    International Journal of Retina and Vitreous, 7
  • [15] Canadian Treat and Extend Analysis Trial with Ranibizumab in Patients with Neovascular AMD: Interim Analysis of the CANTREAT Study
    Kertes, Peter
    Sheidow, Tom
    Williams, Geoff
    Greve, Mark
    Galic, Ivan John
    Rampakakis, Emmanouil
    Bourgault, Bernard
    Courseau, Anne-Sophie
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [16] Canadian Treat and Extend Analysis Trial with Ranibizumab in Patients with Neovascular AMD: Interim Analysis of the CANTREAT Study
    Kertes, Peter
    Sheidow, Thomas G.
    Williams, Geoff
    Greve, Mark
    Galic, Ivan
    Rampakakis, Emmanouil
    Gavalakis, Joanne
    Scarino, Andrea
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [17] Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
    Griffin, David R.
    Richmond, Preston P.
    Olson, John C.
    JOURNAL OF OPHTHALMOLOGY, 2014, 2014
  • [18] The efficacy of aflibercept in the treatment of neovascular age-related macular degeneration previously treated with bevacizumab or ranibizumab
    Hall, Laura
    Zebardast, Nazlee
    Adelman, Ron
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [19] Assessment of Mental Burden of Patients with Neovascular Age-Related Macular Degeneration Treated by Treat-and-Extend Regimen with Intravitreal Ranibizumab
    Kato, Aki
    Yasukawa, Tsutomu
    Sugita, Iichiro
    Yoshida, Munenori
    Nozaki, Miho
    Hirano, Yoshio
    Kondo, Junko
    Abe, Tomohiro
    Sugita, Kimiko
    Okita, Takahide
    Morita, Hiroshi
    Sugitani, Kazuhiko
    Usui, Hideaki
    Niwa, Naomi
    Kato, Fusae
    Ogura, Yuichiro
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [20] Canadian Treat and Extend Analysis Trial with Ranibizumab in Patients with Neovascular AMD: CANTREAT Study One Year Results
    Kertes, Peter
    Sheidow, Tom
    Williams, Geoff
    Greve, Mark
    Galic, Ivan John
    Rampakakis, Emmanouil
    Gavalakis, Joanne
    Scarino, Andrea
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
12345